Tag Archives: biopharmceutical

BIOtechNOW Editor | 01/12/2012

Biopharma Industry Enthusiastic About 2012

Eric Langer

By Eric S. Langer, president and managing partner, BioPlan Associates, Inc. 2012 Annual Study shows budgets, optimism taking a big jump It looks like the biopharma industry is actually weathering the economic downturn quite comfortably. This year we’ve surveyed hundreds of biomanufacturers and suppliers, and the industry is expressing more raw optimism and confidence than at any time in the past 9 years we’ve been surveying this industry. More Spending What this means is that wallets Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , ,
David Thomas | 05/17/2011

Nasdaq Biotech Index re-ranking for next Monday

Twice a year, in May and November, the NASDAQ OMX Group re-ranks the closely watched Nasdaq Biotechnology Index (NBI). This Monday (May 23rd), six companies will be added to the Nasdaq Biotech index and two will be removed. The additions are Achillion Pharmaceuticals (ACHN), AVEO Pharmaceuticals (AVEO), Columbia Laboratories (CBRX), ISTA Pharmaceuticals (ISTA), Pacific Biosciences (PACB) and Zalicus (ZLCS). The two companies to be removed from the NBI are Biodel (BIOD) and China Sky One Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , ,